Global Pneumococcal Polysaccharide Vaccine Market Growth 2026-2032
The global Pneumococcal Polysaccharide Vaccine market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
United States market for Pneumococcal Polysaccharide Vaccine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Pneumococcal Polysaccharide Vaccine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Pneumococcal Polysaccharide Vaccine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Pneumococcal Polysaccharide Vaccine players cover Merck & Co., Pfizer, Sanofi Pasteur, Walvax, Sinovac, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the “Pneumococcal Polysaccharide Vaccine Industry Forecast” looks at past sales and reviews total world Pneumococcal Polysaccharide Vaccine sales in 2025, providing a comprehensive analysis by region and market sector of projected Pneumococcal Polysaccharide Vaccine sales for 2026 through 2032. With Pneumococcal Polysaccharide Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pneumococcal Polysaccharide Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Pneumococcal Polysaccharide Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pneumococcal Polysaccharide Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Pneumococcal Polysaccharide Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pneumococcal Polysaccharide Vaccine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pneumococcal Polysaccharide Vaccine.
This report presents a comprehensive overview, market shares, and growth opportunities of Pneumococcal Polysaccharide Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Pneumococcal Polysaccharide Vaccine market?
What factors are driving Pneumococcal Polysaccharide Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Pneumococcal Polysaccharide Vaccine market opportunities vary by end market size?
How does Pneumococcal Polysaccharide Vaccine break out by Type, by Application?
United States market for Pneumococcal Polysaccharide Vaccine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Pneumococcal Polysaccharide Vaccine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Pneumococcal Polysaccharide Vaccine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Pneumococcal Polysaccharide Vaccine players cover Merck & Co., Pfizer, Sanofi Pasteur, Walvax, Sinovac, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the “Pneumococcal Polysaccharide Vaccine Industry Forecast” looks at past sales and reviews total world Pneumococcal Polysaccharide Vaccine sales in 2025, providing a comprehensive analysis by region and market sector of projected Pneumococcal Polysaccharide Vaccine sales for 2026 through 2032. With Pneumococcal Polysaccharide Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pneumococcal Polysaccharide Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Pneumococcal Polysaccharide Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pneumococcal Polysaccharide Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Pneumococcal Polysaccharide Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pneumococcal Polysaccharide Vaccine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pneumococcal Polysaccharide Vaccine.
This report presents a comprehensive overview, market shares, and growth opportunities of Pneumococcal Polysaccharide Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- PCV13
- PPSV23
- Others
- Hospital
- Centers for Disease Control and Prevention
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Merck & Co.
- Pfizer
- Sanofi Pasteur
- Walvax
- Sinovac
- Sino Biopharm
- Kangtai Bio
- Zhifei Biological
- AIM Bio
- Antejin Biotechnology
What is the 10-year outlook for the global Pneumococcal Polysaccharide Vaccine market?
What factors are driving Pneumococcal Polysaccharide Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Pneumococcal Polysaccharide Vaccine market opportunities vary by end market size?
How does Pneumococcal Polysaccharide Vaccine break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Pneumococcal Polysaccharide Vaccine Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Pneumococcal Polysaccharide Vaccine by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Pneumococcal Polysaccharide Vaccine by Country/Region, 2021, 2025 & 2032
2.2 Pneumococcal Polysaccharide Vaccine Segment by Type
2.2.1 PCV13
2.2.2 PPSV23
2.2.3 Others
2.2.4 Pneumococcal Polysaccharide Vaccine Sales by Type
2.2.4.1 Global Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2021-2026)
2.2.4.2 Global Pneumococcal Polysaccharide Vaccine Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global Pneumococcal Polysaccharide Vaccine Sale Price by Type (2021-2026)
2.3 Pneumococcal Polysaccharide Vaccine Segment by Application
2.3.1 Hospital
2.3.2 Centers for Disease Control and Prevention
2.3.3 Others
2.3.4 Pneumococcal Polysaccharide Vaccine Sales by Application
2.3.4.1 Global Pneumococcal Polysaccharide Vaccine Sale Market Share by Application (2021-2026)
2.3.4.2 Global Pneumococcal Polysaccharide Vaccine Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global Pneumococcal Polysaccharide Vaccine Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Pneumococcal Polysaccharide Vaccine Breakdown Data by Company
3.1.1 Global Pneumococcal Polysaccharide Vaccine Annual Sales by Company (2021-2026)
3.1.2 Global Pneumococcal Polysaccharide Vaccine Sales Market Share by Company (2021-2026)
3.2 Global Pneumococcal Polysaccharide Vaccine Annual Revenue by Company (2021-2026)
3.2.1 Global Pneumococcal Polysaccharide Vaccine Revenue by Company (2021-2026)
3.2.2 Global Pneumococcal Polysaccharide Vaccine Revenue Market Share by Company (2021-2026)
3.3 Global Pneumococcal Polysaccharide Vaccine Sale Price by Company
3.4 Key Manufacturers Pneumococcal Polysaccharide Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Pneumococcal Polysaccharide Vaccine Product Location Distribution
3.4.2 Players Pneumococcal Polysaccharide Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR PNEUMOCOCCAL POLYSACCHARIDE VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Pneumococcal Polysaccharide Vaccine Market Size by Geographic Region (2021-2026)
4.1.1 Global Pneumococcal Polysaccharide Vaccine Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Pneumococcal Polysaccharide Vaccine Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Pneumococcal Polysaccharide Vaccine Market Size by Country/Region (2021-2026)
4.2.1 Global Pneumococcal Polysaccharide Vaccine Annual Sales by Country/Region (2021-2026)
4.2.2 Global Pneumococcal Polysaccharide Vaccine Annual Revenue by Country/Region (2021-2026)
4.3 Americas Pneumococcal Polysaccharide Vaccine Sales Growth
4.4 APAC Pneumococcal Polysaccharide Vaccine Sales Growth
4.5 Europe Pneumococcal Polysaccharide Vaccine Sales Growth
4.6 Middle East & Africa Pneumococcal Polysaccharide Vaccine Sales Growth
5 AMERICAS
5.1 Americas Pneumococcal Polysaccharide Vaccine Sales by Country
5.1.1 Americas Pneumococcal Polysaccharide Vaccine Sales by Country (2021-2026)
5.1.2 Americas Pneumococcal Polysaccharide Vaccine Revenue by Country (2021-2026)
5.2 Americas Pneumococcal Polysaccharide Vaccine Sales by Type (2021-2026)
5.3 Americas Pneumococcal Polysaccharide Vaccine Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pneumococcal Polysaccharide Vaccine Sales by Region
6.1.1 APAC Pneumococcal Polysaccharide Vaccine Sales by Region (2021-2026)
6.1.2 APAC Pneumococcal Polysaccharide Vaccine Revenue by Region (2021-2026)
6.2 APAC Pneumococcal Polysaccharide Vaccine Sales by Type (2021-2026)
6.3 APAC Pneumococcal Polysaccharide Vaccine Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Pneumococcal Polysaccharide Vaccine by Country
7.1.1 Europe Pneumococcal Polysaccharide Vaccine Sales by Country (2021-2026)
7.1.2 Europe Pneumococcal Polysaccharide Vaccine Revenue by Country (2021-2026)
7.2 Europe Pneumococcal Polysaccharide Vaccine Sales by Type (2021-2026)
7.3 Europe Pneumococcal Polysaccharide Vaccine Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Pneumococcal Polysaccharide Vaccine by Country
8.1.1 Middle East & Africa Pneumococcal Polysaccharide Vaccine Sales by Country (2021-2026)
8.1.2 Middle East & Africa Pneumococcal Polysaccharide Vaccine Revenue by Country (2021-2026)
8.2 Middle East & Africa Pneumococcal Polysaccharide Vaccine Sales by Type (2021-2026)
8.3 Middle East & Africa Pneumococcal Polysaccharide Vaccine Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Pneumococcal Polysaccharide Vaccine
10.3 Manufacturing Process Analysis of Pneumococcal Polysaccharide Vaccine
10.4 Industry Chain Structure of Pneumococcal Polysaccharide Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Pneumococcal Polysaccharide Vaccine Distributors
11.3 Pneumococcal Polysaccharide Vaccine Customer
12 WORLD FORECAST REVIEW FOR PNEUMOCOCCAL POLYSACCHARIDE VACCINE BY GEOGRAPHIC REGION
12.1 Global Pneumococcal Polysaccharide Vaccine Market Size Forecast by Region
12.1.1 Global Pneumococcal Polysaccharide Vaccine Forecast by Region (2027-2032)
12.1.2 Global Pneumococcal Polysaccharide Vaccine Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Pneumococcal Polysaccharide Vaccine Forecast by Type (2027-2032)
12.7 Global Pneumococcal Polysaccharide Vaccine Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Merck & Co.
13.1.1 Merck & Co. Company Information
13.1.2 Merck & Co. Pneumococcal Polysaccharide Vaccine Product Portfolios and Specifications
13.1.3 Merck & Co. Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Merck & Co. Main Business Overview
13.1.5 Merck & Co. Latest Developments
13.2 Pfizer
13.2.1 Pfizer Company Information
13.2.2 Pfizer Pneumococcal Polysaccharide Vaccine Product Portfolios and Specifications
13.2.3 Pfizer Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Pfizer Main Business Overview
13.2.5 Pfizer Latest Developments
13.3 Sanofi Pasteur
13.3.1 Sanofi Pasteur Company Information
13.3.2 Sanofi Pasteur Pneumococcal Polysaccharide Vaccine Product Portfolios and Specifications
13.3.3 Sanofi Pasteur Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Sanofi Pasteur Main Business Overview
13.3.5 Sanofi Pasteur Latest Developments
13.4 Walvax
13.4.1 Walvax Company Information
13.4.2 Walvax Pneumococcal Polysaccharide Vaccine Product Portfolios and Specifications
13.4.3 Walvax Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Walvax Main Business Overview
13.4.5 Walvax Latest Developments
13.5 Sinovac
13.5.1 Sinovac Company Information
13.5.2 Sinovac Pneumococcal Polysaccharide Vaccine Product Portfolios and Specifications
13.5.3 Sinovac Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Sinovac Main Business Overview
13.5.5 Sinovac Latest Developments
13.6 Sino Biopharm
13.6.1 Sino Biopharm Company Information
13.6.2 Sino Biopharm Pneumococcal Polysaccharide Vaccine Product Portfolios and Specifications
13.6.3 Sino Biopharm Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Sino Biopharm Main Business Overview
13.6.5 Sino Biopharm Latest Developments
13.7 Kangtai Bio
13.7.1 Kangtai Bio Company Information
13.7.2 Kangtai Bio Pneumococcal Polysaccharide Vaccine Product Portfolios and Specifications
13.7.3 Kangtai Bio Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Kangtai Bio Main Business Overview
13.7.5 Kangtai Bio Latest Developments
13.8 Zhifei Biological
13.8.1 Zhifei Biological Company Information
13.8.2 Zhifei Biological Pneumococcal Polysaccharide Vaccine Product Portfolios and Specifications
13.8.3 Zhifei Biological Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Zhifei Biological Main Business Overview
13.8.5 Zhifei Biological Latest Developments
13.9 AIM Bio
13.9.1 AIM Bio Company Information
13.9.2 AIM Bio Pneumococcal Polysaccharide Vaccine Product Portfolios and Specifications
13.9.3 AIM Bio Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 AIM Bio Main Business Overview
13.9.5 AIM Bio Latest Developments
13.10 Antejin Biotechnology
13.10.1 Antejin Biotechnology Company Information
13.10.2 Antejin Biotechnology Pneumococcal Polysaccharide Vaccine Product Portfolios and Specifications
13.10.3 Antejin Biotechnology Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Antejin Biotechnology Main Business Overview
13.10.5 Antejin Biotechnology Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Pneumococcal Polysaccharide Vaccine Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Pneumococcal Polysaccharide Vaccine by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Pneumococcal Polysaccharide Vaccine by Country/Region, 2021, 2025 & 2032
2.2 Pneumococcal Polysaccharide Vaccine Segment by Type
2.2.1 PCV13
2.2.2 PPSV23
2.2.3 Others
2.2.4 Pneumococcal Polysaccharide Vaccine Sales by Type
2.2.4.1 Global Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2021-2026)
2.2.4.2 Global Pneumococcal Polysaccharide Vaccine Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global Pneumococcal Polysaccharide Vaccine Sale Price by Type (2021-2026)
2.3 Pneumococcal Polysaccharide Vaccine Segment by Application
2.3.1 Hospital
2.3.2 Centers for Disease Control and Prevention
2.3.3 Others
2.3.4 Pneumococcal Polysaccharide Vaccine Sales by Application
2.3.4.1 Global Pneumococcal Polysaccharide Vaccine Sale Market Share by Application (2021-2026)
2.3.4.2 Global Pneumococcal Polysaccharide Vaccine Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global Pneumococcal Polysaccharide Vaccine Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Pneumococcal Polysaccharide Vaccine Breakdown Data by Company
3.1.1 Global Pneumococcal Polysaccharide Vaccine Annual Sales by Company (2021-2026)
3.1.2 Global Pneumococcal Polysaccharide Vaccine Sales Market Share by Company (2021-2026)
3.2 Global Pneumococcal Polysaccharide Vaccine Annual Revenue by Company (2021-2026)
3.2.1 Global Pneumococcal Polysaccharide Vaccine Revenue by Company (2021-2026)
3.2.2 Global Pneumococcal Polysaccharide Vaccine Revenue Market Share by Company (2021-2026)
3.3 Global Pneumococcal Polysaccharide Vaccine Sale Price by Company
3.4 Key Manufacturers Pneumococcal Polysaccharide Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Pneumococcal Polysaccharide Vaccine Product Location Distribution
3.4.2 Players Pneumococcal Polysaccharide Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR PNEUMOCOCCAL POLYSACCHARIDE VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Pneumococcal Polysaccharide Vaccine Market Size by Geographic Region (2021-2026)
4.1.1 Global Pneumococcal Polysaccharide Vaccine Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Pneumococcal Polysaccharide Vaccine Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Pneumococcal Polysaccharide Vaccine Market Size by Country/Region (2021-2026)
4.2.1 Global Pneumococcal Polysaccharide Vaccine Annual Sales by Country/Region (2021-2026)
4.2.2 Global Pneumococcal Polysaccharide Vaccine Annual Revenue by Country/Region (2021-2026)
4.3 Americas Pneumococcal Polysaccharide Vaccine Sales Growth
4.4 APAC Pneumococcal Polysaccharide Vaccine Sales Growth
4.5 Europe Pneumococcal Polysaccharide Vaccine Sales Growth
4.6 Middle East & Africa Pneumococcal Polysaccharide Vaccine Sales Growth
5 AMERICAS
5.1 Americas Pneumococcal Polysaccharide Vaccine Sales by Country
5.1.1 Americas Pneumococcal Polysaccharide Vaccine Sales by Country (2021-2026)
5.1.2 Americas Pneumococcal Polysaccharide Vaccine Revenue by Country (2021-2026)
5.2 Americas Pneumococcal Polysaccharide Vaccine Sales by Type (2021-2026)
5.3 Americas Pneumococcal Polysaccharide Vaccine Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pneumococcal Polysaccharide Vaccine Sales by Region
6.1.1 APAC Pneumococcal Polysaccharide Vaccine Sales by Region (2021-2026)
6.1.2 APAC Pneumococcal Polysaccharide Vaccine Revenue by Region (2021-2026)
6.2 APAC Pneumococcal Polysaccharide Vaccine Sales by Type (2021-2026)
6.3 APAC Pneumococcal Polysaccharide Vaccine Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Pneumococcal Polysaccharide Vaccine by Country
7.1.1 Europe Pneumococcal Polysaccharide Vaccine Sales by Country (2021-2026)
7.1.2 Europe Pneumococcal Polysaccharide Vaccine Revenue by Country (2021-2026)
7.2 Europe Pneumococcal Polysaccharide Vaccine Sales by Type (2021-2026)
7.3 Europe Pneumococcal Polysaccharide Vaccine Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Pneumococcal Polysaccharide Vaccine by Country
8.1.1 Middle East & Africa Pneumococcal Polysaccharide Vaccine Sales by Country (2021-2026)
8.1.2 Middle East & Africa Pneumococcal Polysaccharide Vaccine Revenue by Country (2021-2026)
8.2 Middle East & Africa Pneumococcal Polysaccharide Vaccine Sales by Type (2021-2026)
8.3 Middle East & Africa Pneumococcal Polysaccharide Vaccine Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Pneumococcal Polysaccharide Vaccine
10.3 Manufacturing Process Analysis of Pneumococcal Polysaccharide Vaccine
10.4 Industry Chain Structure of Pneumococcal Polysaccharide Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Pneumococcal Polysaccharide Vaccine Distributors
11.3 Pneumococcal Polysaccharide Vaccine Customer
12 WORLD FORECAST REVIEW FOR PNEUMOCOCCAL POLYSACCHARIDE VACCINE BY GEOGRAPHIC REGION
12.1 Global Pneumococcal Polysaccharide Vaccine Market Size Forecast by Region
12.1.1 Global Pneumococcal Polysaccharide Vaccine Forecast by Region (2027-2032)
12.1.2 Global Pneumococcal Polysaccharide Vaccine Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Pneumococcal Polysaccharide Vaccine Forecast by Type (2027-2032)
12.7 Global Pneumococcal Polysaccharide Vaccine Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Merck & Co.
13.1.1 Merck & Co. Company Information
13.1.2 Merck & Co. Pneumococcal Polysaccharide Vaccine Product Portfolios and Specifications
13.1.3 Merck & Co. Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Merck & Co. Main Business Overview
13.1.5 Merck & Co. Latest Developments
13.2 Pfizer
13.2.1 Pfizer Company Information
13.2.2 Pfizer Pneumococcal Polysaccharide Vaccine Product Portfolios and Specifications
13.2.3 Pfizer Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Pfizer Main Business Overview
13.2.5 Pfizer Latest Developments
13.3 Sanofi Pasteur
13.3.1 Sanofi Pasteur Company Information
13.3.2 Sanofi Pasteur Pneumococcal Polysaccharide Vaccine Product Portfolios and Specifications
13.3.3 Sanofi Pasteur Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Sanofi Pasteur Main Business Overview
13.3.5 Sanofi Pasteur Latest Developments
13.4 Walvax
13.4.1 Walvax Company Information
13.4.2 Walvax Pneumococcal Polysaccharide Vaccine Product Portfolios and Specifications
13.4.3 Walvax Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Walvax Main Business Overview
13.4.5 Walvax Latest Developments
13.5 Sinovac
13.5.1 Sinovac Company Information
13.5.2 Sinovac Pneumococcal Polysaccharide Vaccine Product Portfolios and Specifications
13.5.3 Sinovac Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Sinovac Main Business Overview
13.5.5 Sinovac Latest Developments
13.6 Sino Biopharm
13.6.1 Sino Biopharm Company Information
13.6.2 Sino Biopharm Pneumococcal Polysaccharide Vaccine Product Portfolios and Specifications
13.6.3 Sino Biopharm Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Sino Biopharm Main Business Overview
13.6.5 Sino Biopharm Latest Developments
13.7 Kangtai Bio
13.7.1 Kangtai Bio Company Information
13.7.2 Kangtai Bio Pneumococcal Polysaccharide Vaccine Product Portfolios and Specifications
13.7.3 Kangtai Bio Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Kangtai Bio Main Business Overview
13.7.5 Kangtai Bio Latest Developments
13.8 Zhifei Biological
13.8.1 Zhifei Biological Company Information
13.8.2 Zhifei Biological Pneumococcal Polysaccharide Vaccine Product Portfolios and Specifications
13.8.3 Zhifei Biological Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Zhifei Biological Main Business Overview
13.8.5 Zhifei Biological Latest Developments
13.9 AIM Bio
13.9.1 AIM Bio Company Information
13.9.2 AIM Bio Pneumococcal Polysaccharide Vaccine Product Portfolios and Specifications
13.9.3 AIM Bio Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 AIM Bio Main Business Overview
13.9.5 AIM Bio Latest Developments
13.10 Antejin Biotechnology
13.10.1 Antejin Biotechnology Company Information
13.10.2 Antejin Biotechnology Pneumococcal Polysaccharide Vaccine Product Portfolios and Specifications
13.10.3 Antejin Biotechnology Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Antejin Biotechnology Main Business Overview
13.10.5 Antejin Biotechnology Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Pneumococcal Polysaccharide Vaccine Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Pneumococcal Polysaccharide Vaccine Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of PCV13
Table 4. Major Players of PPSV23
Table 5. Major Players of Others
Table 6. Global Pneumococcal Polysaccharide Vaccine Sales by Type (2021-2026) & (Dose)
Table 7. Global Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2021-2026)
Table 8. Global Pneumococcal Polysaccharide Vaccine Revenue by Type (2021-2026) & ($ million)
Table 9. Global Pneumococcal Polysaccharide Vaccine Revenue Market Share by Type (2021-2026)
Table 10. Global Pneumococcal Polysaccharide Vaccine Sale Price by Type (2021-2026) & (US$/Dose)
Table 11. Global Pneumococcal Polysaccharide Vaccine Sale by Application (2021-2026) & (Dose)
Table 12. Global Pneumococcal Polysaccharide Vaccine Sale Market Share by Application (2021-2026)
Table 13. Global Pneumococcal Polysaccharide Vaccine Revenue by Application (2021-2026) & ($ million)
Table 14. Global Pneumococcal Polysaccharide Vaccine Revenue Market Share by Application (2021-2026)
Table 15. Global Pneumococcal Polysaccharide Vaccine Sale Price by Application (2021-2026) & (US$/Dose)
Table 16. Global Pneumococcal Polysaccharide Vaccine Sales by Company (2021-2026) & (Dose)
Table 17. Global Pneumococcal Polysaccharide Vaccine Sales Market Share by Company (2021-2026)
Table 18. Global Pneumococcal Polysaccharide Vaccine Revenue by Company (2021-2026) & ($ millions)
Table 19. Global Pneumococcal Polysaccharide Vaccine Revenue Market Share by Company (2021-2026)
Table 20. Global Pneumococcal Polysaccharide Vaccine Sale Price by Company (2021-2026) & (US$/Dose)
Table 21. Key Manufacturers Pneumococcal Polysaccharide Vaccine Producing Area Distribution and Sales Area
Table 22. Players Pneumococcal Polysaccharide Vaccine Products Offered
Table 23. Pneumococcal Polysaccharide Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Pneumococcal Polysaccharide Vaccine Sales by Geographic Region (2021-2026) & (Dose)
Table 27. Global Pneumococcal Polysaccharide Vaccine Sales Market Share Geographic Region (2021-2026)
Table 28. Global Pneumococcal Polysaccharide Vaccine Revenue by Geographic Region (2021-2026) & ($ millions)
Table 29. Global Pneumococcal Polysaccharide Vaccine Revenue Market Share by Geographic Region (2021-2026)
Table 30. Global Pneumococcal Polysaccharide Vaccine Sales by Country/Region (2021-2026) & (Dose)
Table 31. Global Pneumococcal Polysaccharide Vaccine Sales Market Share by Country/Region (2021-2026)
Table 32. Global Pneumococcal Polysaccharide Vaccine Revenue by Country/Region (2021-2026) & ($ millions)
Table 33. Global Pneumococcal Polysaccharide Vaccine Revenue Market Share by Country/Region (2021-2026)
Table 34. Americas Pneumococcal Polysaccharide Vaccine Sales by Country (2021-2026) & (Dose)
Table 35. Americas Pneumococcal Polysaccharide Vaccine Sales Market Share by Country (2021-2026)
Table 36. Americas Pneumococcal Polysaccharide Vaccine Revenue by Country (2021-2026) & ($ millions)
Table 37. Americas Pneumococcal Polysaccharide Vaccine Sales by Type (2021-2026) & (Dose)
Table 38. Americas Pneumococcal Polysaccharide Vaccine Sales by Application (2021-2026) & (Dose)
Table 39. APAC Pneumococcal Polysaccharide Vaccine Sales by Region (2021-2026) & (Dose)
Table 40. APAC Pneumococcal Polysaccharide Vaccine Sales Market Share by Region (2021-2026)
Table 41. APAC Pneumococcal Polysaccharide Vaccine Revenue by Region (2021-2026) & ($ millions)
Table 42. APAC Pneumococcal Polysaccharide Vaccine Sales by Type (2021-2026) & (Dose)
Table 43. APAC Pneumococcal Polysaccharide Vaccine Sales by Application (2021-2026) & (Dose)
Table 44. Europe Pneumococcal Polysaccharide Vaccine Sales by Country (2021-2026) & (Dose)
Table 45. Europe Pneumococcal Polysaccharide Vaccine Revenue by Country (2021-2026) & ($ millions)
Table 46. Europe Pneumococcal Polysaccharide Vaccine Sales by Type (2021-2026) & (Dose)
Table 47. Europe Pneumococcal Polysaccharide Vaccine Sales by Application (2021-2026) & (Dose)
Table 48. Middle East & Africa Pneumococcal Polysaccharide Vaccine Sales by Country (2021-2026) & (Dose)
Table 49. Middle East & Africa Pneumococcal Polysaccharide Vaccine Revenue Market Share by Country (2021-2026)
Table 50. Middle East & Africa Pneumococcal Polysaccharide Vaccine Sales by Type (2021-2026) & (Dose)
Table 51. Middle East & Africa Pneumococcal Polysaccharide Vaccine Sales by Application (2021-2026) & (Dose)
Table 52. Key Market Drivers & Growth Opportunities of Pneumococcal Polysaccharide Vaccine
Table 53. Key Market Challenges & Risks of Pneumococcal Polysaccharide Vaccine
Table 54. Key Industry Trends of Pneumococcal Polysaccharide Vaccine
Table 55. Pneumococcal Polysaccharide Vaccine Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Pneumococcal Polysaccharide Vaccine Distributors List
Table 58. Pneumococcal Polysaccharide Vaccine Customer List
Table 59. Global Pneumococcal Polysaccharide Vaccine Sales Forecast by Region (2027-2032) & (Dose)
Table 60. Global Pneumococcal Polysaccharide Vaccine Revenue Forecast by Region (2027-2032) & ($ millions)
Table 61. Americas Pneumococcal Polysaccharide Vaccine Sales Forecast by Country (2027-2032) & (Dose)
Table 62. Americas Pneumococcal Polysaccharide Vaccine Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 63. APAC Pneumococcal Polysaccharide Vaccine Sales Forecast by Region (2027-2032) & (Dose)
Table 64. APAC Pneumococcal Polysaccharide Vaccine Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 65. Europe Pneumococcal Polysaccharide Vaccine Sales Forecast by Country (2027-2032) & (Dose)
Table 66. Europe Pneumococcal Polysaccharide Vaccine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 67. Middle East & Africa Pneumococcal Polysaccharide Vaccine Sales Forecast by Country (2027-2032) & (Dose)
Table 68. Middle East & Africa Pneumococcal Polysaccharide Vaccine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 69. Global Pneumococcal Polysaccharide Vaccine Sales Forecast by Type (2027-2032) & (Dose)
Table 70. Global Pneumococcal Polysaccharide Vaccine Revenue Forecast by Type (2027-2032) & ($ millions)
Table 71. Global Pneumococcal Polysaccharide Vaccine Sales Forecast by Application (2027-2032) & (Dose)
Table 72. Global Pneumococcal Polysaccharide Vaccine Revenue Forecast by Application (2027-2032) & ($ millions)
Table 73. Merck & Co. Basic Information, Pneumococcal Polysaccharide Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 74. Merck & Co. Pneumococcal Polysaccharide Vaccine Product Portfolios and Specifications
Table 75. Merck & Co. Pneumococcal Polysaccharide Vaccine Sales (Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 76. Merck & Co. Main Business
Table 77. Merck & Co. Latest Developments
Table 78. Pfizer Basic Information, Pneumococcal Polysaccharide Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 79. Pfizer Pneumococcal Polysaccharide Vaccine Product Portfolios and Specifications
Table 80. Pfizer Pneumococcal Polysaccharide Vaccine Sales (Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 81. Pfizer Main Business
Table 82. Pfizer Latest Developments
Table 83. Sanofi Pasteur Basic Information, Pneumococcal Polysaccharide Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 84. Sanofi Pasteur Pneumococcal Polysaccharide Vaccine Product Portfolios and Specifications
Table 85. Sanofi Pasteur Pneumococcal Polysaccharide Vaccine Sales (Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 86. Sanofi Pasteur Main Business
Table 87. Sanofi Pasteur Latest Developments
Table 88. Walvax Basic Information, Pneumococcal Polysaccharide Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 89. Walvax Pneumococcal Polysaccharide Vaccine Product Portfolios and Specifications
Table 90. Walvax Pneumococcal Polysaccharide Vaccine Sales (Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 91. Walvax Main Business
Table 92. Walvax Latest Developments
Table 93. Sinovac Basic Information, Pneumococcal Polysaccharide Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 94. Sinovac Pneumococcal Polysaccharide Vaccine Product Portfolios and Specifications
Table 95. Sinovac Pneumococcal Polysaccharide Vaccine Sales (Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 96. Sinovac Main Business
Table 97. Sinovac Latest Developments
Table 98. Sino Biopharm Basic Information, Pneumococcal Polysaccharide Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 99. Sino Biopharm Pneumococcal Polysaccharide Vaccine Product Portfolios and Specifications
Table 100. Sino Biopharm Pneumococcal Polysaccharide Vaccine Sales (Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 101. Sino Biopharm Main Business
Table 102. Sino Biopharm Latest Developments
Table 103. Kangtai Bio Basic Information, Pneumococcal Polysaccharide Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 104. Kangtai Bio Pneumococcal Polysaccharide Vaccine Product Portfolios and Specifications
Table 105. Kangtai Bio Pneumococcal Polysaccharide Vaccine Sales (Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 106. Kangtai Bio Main Business
Table 107. Kangtai Bio Latest Developments
Table 108. Zhifei Biological Basic Information, Pneumococcal Polysaccharide Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 109. Zhifei Biological Pneumococcal Polysaccharide Vaccine Product Portfolios and Specifications
Table 110. Zhifei Biological Pneumococcal Polysaccharide Vaccine Sales (Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 111. Zhifei Biological Main Business
Table 112. Zhifei Biological Latest Developments
Table 113. AIM Bio Basic Information, Pneumococcal Polysaccharide Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 114. AIM Bio Pneumococcal Polysaccharide Vaccine Product Portfolios and Specifications
Table 115. AIM Bio Pneumococcal Polysaccharide Vaccine Sales (Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 116. AIM Bio Main Business
Table 117. AIM Bio Latest Developments
Table 118. Antejin Biotechnology Basic Information, Pneumococcal Polysaccharide Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 119. Antejin Biotechnology Pneumococcal Polysaccharide Vaccine Product Portfolios and Specifications
Table 120. Antejin Biotechnology Pneumococcal Polysaccharide Vaccine Sales (Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 121. Antejin Biotechnology Main Business
Table 122. Antejin Biotechnology Latest Developments
Table 1. Pneumococcal Polysaccharide Vaccine Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Pneumococcal Polysaccharide Vaccine Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of PCV13
Table 4. Major Players of PPSV23
Table 5. Major Players of Others
Table 6. Global Pneumococcal Polysaccharide Vaccine Sales by Type (2021-2026) & (Dose)
Table 7. Global Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2021-2026)
Table 8. Global Pneumococcal Polysaccharide Vaccine Revenue by Type (2021-2026) & ($ million)
Table 9. Global Pneumococcal Polysaccharide Vaccine Revenue Market Share by Type (2021-2026)
Table 10. Global Pneumococcal Polysaccharide Vaccine Sale Price by Type (2021-2026) & (US$/Dose)
Table 11. Global Pneumococcal Polysaccharide Vaccine Sale by Application (2021-2026) & (Dose)
Table 12. Global Pneumococcal Polysaccharide Vaccine Sale Market Share by Application (2021-2026)
Table 13. Global Pneumococcal Polysaccharide Vaccine Revenue by Application (2021-2026) & ($ million)
Table 14. Global Pneumococcal Polysaccharide Vaccine Revenue Market Share by Application (2021-2026)
Table 15. Global Pneumococcal Polysaccharide Vaccine Sale Price by Application (2021-2026) & (US$/Dose)
Table 16. Global Pneumococcal Polysaccharide Vaccine Sales by Company (2021-2026) & (Dose)
Table 17. Global Pneumococcal Polysaccharide Vaccine Sales Market Share by Company (2021-2026)
Table 18. Global Pneumococcal Polysaccharide Vaccine Revenue by Company (2021-2026) & ($ millions)
Table 19. Global Pneumococcal Polysaccharide Vaccine Revenue Market Share by Company (2021-2026)
Table 20. Global Pneumococcal Polysaccharide Vaccine Sale Price by Company (2021-2026) & (US$/Dose)
Table 21. Key Manufacturers Pneumococcal Polysaccharide Vaccine Producing Area Distribution and Sales Area
Table 22. Players Pneumococcal Polysaccharide Vaccine Products Offered
Table 23. Pneumococcal Polysaccharide Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Pneumococcal Polysaccharide Vaccine Sales by Geographic Region (2021-2026) & (Dose)
Table 27. Global Pneumococcal Polysaccharide Vaccine Sales Market Share Geographic Region (2021-2026)
Table 28. Global Pneumococcal Polysaccharide Vaccine Revenue by Geographic Region (2021-2026) & ($ millions)
Table 29. Global Pneumococcal Polysaccharide Vaccine Revenue Market Share by Geographic Region (2021-2026)
Table 30. Global Pneumococcal Polysaccharide Vaccine Sales by Country/Region (2021-2026) & (Dose)
Table 31. Global Pneumococcal Polysaccharide Vaccine Sales Market Share by Country/Region (2021-2026)
Table 32. Global Pneumococcal Polysaccharide Vaccine Revenue by Country/Region (2021-2026) & ($ millions)
Table 33. Global Pneumococcal Polysaccharide Vaccine Revenue Market Share by Country/Region (2021-2026)
Table 34. Americas Pneumococcal Polysaccharide Vaccine Sales by Country (2021-2026) & (Dose)
Table 35. Americas Pneumococcal Polysaccharide Vaccine Sales Market Share by Country (2021-2026)
Table 36. Americas Pneumococcal Polysaccharide Vaccine Revenue by Country (2021-2026) & ($ millions)
Table 37. Americas Pneumococcal Polysaccharide Vaccine Sales by Type (2021-2026) & (Dose)
Table 38. Americas Pneumococcal Polysaccharide Vaccine Sales by Application (2021-2026) & (Dose)
Table 39. APAC Pneumococcal Polysaccharide Vaccine Sales by Region (2021-2026) & (Dose)
Table 40. APAC Pneumococcal Polysaccharide Vaccine Sales Market Share by Region (2021-2026)
Table 41. APAC Pneumococcal Polysaccharide Vaccine Revenue by Region (2021-2026) & ($ millions)
Table 42. APAC Pneumococcal Polysaccharide Vaccine Sales by Type (2021-2026) & (Dose)
Table 43. APAC Pneumococcal Polysaccharide Vaccine Sales by Application (2021-2026) & (Dose)
Table 44. Europe Pneumococcal Polysaccharide Vaccine Sales by Country (2021-2026) & (Dose)
Table 45. Europe Pneumococcal Polysaccharide Vaccine Revenue by Country (2021-2026) & ($ millions)
Table 46. Europe Pneumococcal Polysaccharide Vaccine Sales by Type (2021-2026) & (Dose)
Table 47. Europe Pneumococcal Polysaccharide Vaccine Sales by Application (2021-2026) & (Dose)
Table 48. Middle East & Africa Pneumococcal Polysaccharide Vaccine Sales by Country (2021-2026) & (Dose)
Table 49. Middle East & Africa Pneumococcal Polysaccharide Vaccine Revenue Market Share by Country (2021-2026)
Table 50. Middle East & Africa Pneumococcal Polysaccharide Vaccine Sales by Type (2021-2026) & (Dose)
Table 51. Middle East & Africa Pneumococcal Polysaccharide Vaccine Sales by Application (2021-2026) & (Dose)
Table 52. Key Market Drivers & Growth Opportunities of Pneumococcal Polysaccharide Vaccine
Table 53. Key Market Challenges & Risks of Pneumococcal Polysaccharide Vaccine
Table 54. Key Industry Trends of Pneumococcal Polysaccharide Vaccine
Table 55. Pneumococcal Polysaccharide Vaccine Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Pneumococcal Polysaccharide Vaccine Distributors List
Table 58. Pneumococcal Polysaccharide Vaccine Customer List
Table 59. Global Pneumococcal Polysaccharide Vaccine Sales Forecast by Region (2027-2032) & (Dose)
Table 60. Global Pneumococcal Polysaccharide Vaccine Revenue Forecast by Region (2027-2032) & ($ millions)
Table 61. Americas Pneumococcal Polysaccharide Vaccine Sales Forecast by Country (2027-2032) & (Dose)
Table 62. Americas Pneumococcal Polysaccharide Vaccine Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 63. APAC Pneumococcal Polysaccharide Vaccine Sales Forecast by Region (2027-2032) & (Dose)
Table 64. APAC Pneumococcal Polysaccharide Vaccine Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 65. Europe Pneumococcal Polysaccharide Vaccine Sales Forecast by Country (2027-2032) & (Dose)
Table 66. Europe Pneumococcal Polysaccharide Vaccine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 67. Middle East & Africa Pneumococcal Polysaccharide Vaccine Sales Forecast by Country (2027-2032) & (Dose)
Table 68. Middle East & Africa Pneumococcal Polysaccharide Vaccine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 69. Global Pneumococcal Polysaccharide Vaccine Sales Forecast by Type (2027-2032) & (Dose)
Table 70. Global Pneumococcal Polysaccharide Vaccine Revenue Forecast by Type (2027-2032) & ($ millions)
Table 71. Global Pneumococcal Polysaccharide Vaccine Sales Forecast by Application (2027-2032) & (Dose)
Table 72. Global Pneumococcal Polysaccharide Vaccine Revenue Forecast by Application (2027-2032) & ($ millions)
Table 73. Merck & Co. Basic Information, Pneumococcal Polysaccharide Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 74. Merck & Co. Pneumococcal Polysaccharide Vaccine Product Portfolios and Specifications
Table 75. Merck & Co. Pneumococcal Polysaccharide Vaccine Sales (Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 76. Merck & Co. Main Business
Table 77. Merck & Co. Latest Developments
Table 78. Pfizer Basic Information, Pneumococcal Polysaccharide Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 79. Pfizer Pneumococcal Polysaccharide Vaccine Product Portfolios and Specifications
Table 80. Pfizer Pneumococcal Polysaccharide Vaccine Sales (Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 81. Pfizer Main Business
Table 82. Pfizer Latest Developments
Table 83. Sanofi Pasteur Basic Information, Pneumococcal Polysaccharide Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 84. Sanofi Pasteur Pneumococcal Polysaccharide Vaccine Product Portfolios and Specifications
Table 85. Sanofi Pasteur Pneumococcal Polysaccharide Vaccine Sales (Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 86. Sanofi Pasteur Main Business
Table 87. Sanofi Pasteur Latest Developments
Table 88. Walvax Basic Information, Pneumococcal Polysaccharide Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 89. Walvax Pneumococcal Polysaccharide Vaccine Product Portfolios and Specifications
Table 90. Walvax Pneumococcal Polysaccharide Vaccine Sales (Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 91. Walvax Main Business
Table 92. Walvax Latest Developments
Table 93. Sinovac Basic Information, Pneumococcal Polysaccharide Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 94. Sinovac Pneumococcal Polysaccharide Vaccine Product Portfolios and Specifications
Table 95. Sinovac Pneumococcal Polysaccharide Vaccine Sales (Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 96. Sinovac Main Business
Table 97. Sinovac Latest Developments
Table 98. Sino Biopharm Basic Information, Pneumococcal Polysaccharide Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 99. Sino Biopharm Pneumococcal Polysaccharide Vaccine Product Portfolios and Specifications
Table 100. Sino Biopharm Pneumococcal Polysaccharide Vaccine Sales (Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 101. Sino Biopharm Main Business
Table 102. Sino Biopharm Latest Developments
Table 103. Kangtai Bio Basic Information, Pneumococcal Polysaccharide Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 104. Kangtai Bio Pneumococcal Polysaccharide Vaccine Product Portfolios and Specifications
Table 105. Kangtai Bio Pneumococcal Polysaccharide Vaccine Sales (Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 106. Kangtai Bio Main Business
Table 107. Kangtai Bio Latest Developments
Table 108. Zhifei Biological Basic Information, Pneumococcal Polysaccharide Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 109. Zhifei Biological Pneumococcal Polysaccharide Vaccine Product Portfolios and Specifications
Table 110. Zhifei Biological Pneumococcal Polysaccharide Vaccine Sales (Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 111. Zhifei Biological Main Business
Table 112. Zhifei Biological Latest Developments
Table 113. AIM Bio Basic Information, Pneumococcal Polysaccharide Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 114. AIM Bio Pneumococcal Polysaccharide Vaccine Product Portfolios and Specifications
Table 115. AIM Bio Pneumococcal Polysaccharide Vaccine Sales (Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 116. AIM Bio Main Business
Table 117. AIM Bio Latest Developments
Table 118. Antejin Biotechnology Basic Information, Pneumococcal Polysaccharide Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 119. Antejin Biotechnology Pneumococcal Polysaccharide Vaccine Product Portfolios and Specifications
Table 120. Antejin Biotechnology Pneumococcal Polysaccharide Vaccine Sales (Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 121. Antejin Biotechnology Main Business
Table 122. Antejin Biotechnology Latest Developments
LIST OF FIGURES
Figure 1. Picture of Pneumococcal Polysaccharide Vaccine
Figure 2. Pneumococcal Polysaccharide Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Pneumococcal Polysaccharide Vaccine Sales Growth Rate 2021-2032 (Dose)
Figure 7. Global Pneumococcal Polysaccharide Vaccine Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Pneumococcal Polysaccharide Vaccine Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Pneumococcal Polysaccharide Vaccine Sales Market Share by Country/Region (2025)
Figure 10. Pneumococcal Polysaccharide Vaccine Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of PCV13
Figure 12. Product Picture of PPSV23
Figure 13. Product Picture of Others
Figure 14. Global Pneumococcal Polysaccharide Vaccine Sales Market Share by Type in 2026
Figure 15. Global Pneumococcal Polysaccharide Vaccine Revenue Market Share by Type (2021-2026)
Figure 16. Pneumococcal Polysaccharide Vaccine Consumed in Hospital
Figure 17. Global Pneumococcal Polysaccharide Vaccine Market: Hospital (2021-2026) & (Dose)
Figure 18. Pneumococcal Polysaccharide Vaccine Consumed in Centers for Disease Control and Prevention
Figure 19. Global Pneumococcal Polysaccharide Vaccine Market: Centers for Disease Control and Prevention (2021-2026) & (Dose)
Figure 20. Pneumococcal Polysaccharide Vaccine Consumed in Others
Figure 21. Global Pneumococcal Polysaccharide Vaccine Market: Others (2021-2026) & (Dose)
Figure 22. Global Pneumococcal Polysaccharide Vaccine Sale Market Share by Application (2025)
Figure 23. Global Pneumococcal Polysaccharide Vaccine Revenue Market Share by Application in 2026
Figure 24. Pneumococcal Polysaccharide Vaccine Sales by Company in 2026 (Dose)
Figure 25. Global Pneumococcal Polysaccharide Vaccine Sales Market Share by Company in 2026
Figure 26. Pneumococcal Polysaccharide Vaccine Revenue by Company in 2026 ($ millions)
Figure 27. Global Pneumococcal Polysaccharide Vaccine Revenue Market Share by Company in 2026
Figure 28. Global Pneumococcal Polysaccharide Vaccine Sales Market Share by Geographic Region (2021-2026)
Figure 29. Global Pneumococcal Polysaccharide Vaccine Revenue Market Share by Geographic Region in 2026
Figure 30. Americas Pneumococcal Polysaccharide Vaccine Sales 2021-2026 (Dose)
Figure 31. Americas Pneumococcal Polysaccharide Vaccine Revenue 2021-2026 ($ millions)
Figure 32. APAC Pneumococcal Polysaccharide Vaccine Sales 2021-2026 (Dose)
Figure 33. APAC Pneumococcal Polysaccharide Vaccine Revenue 2021-2026 ($ millions)
Figure 34. Europe Pneumococcal Polysaccharide Vaccine Sales 2021-2026 (Dose)
Figure 35. Europe Pneumococcal Polysaccharide Vaccine Revenue 2021-2026 ($ millions)
Figure 36. Middle East & Africa Pneumococcal Polysaccharide Vaccine Sales 2021-2026 (Dose)
Figure 37. Middle East & Africa Pneumococcal Polysaccharide Vaccine Revenue 2021-2026 ($ millions)
Figure 38. Americas Pneumococcal Polysaccharide Vaccine Sales Market Share by Country in 2026
Figure 39. Americas Pneumococcal Polysaccharide Vaccine Revenue Market Share by Country (2021-2026)
Figure 40. Americas Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2021-2026)
Figure 41. Americas Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2021-2026)
Figure 42. United States Pneumococcal Polysaccharide Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 43. Canada Pneumococcal Polysaccharide Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 44. Mexico Pneumococcal Polysaccharide Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 45. Brazil Pneumococcal Polysaccharide Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 46. APAC Pneumococcal Polysaccharide Vaccine Sales Market Share by Region in 2026
Figure 47. APAC Pneumococcal Polysaccharide Vaccine Revenue Market Share by Region (2021-2026)
Figure 48. APAC Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2021-2026)
Figure 49. APAC Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2021-2026)
Figure 50. China Pneumococcal Polysaccharide Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 51. Japan Pneumococcal Polysaccharide Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 52. South Korea Pneumococcal Polysaccharide Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 53. Southeast Asia Pneumococcal Polysaccharide Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 54. India Pneumococcal Polysaccharide Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 55. Australia Pneumococcal Polysaccharide Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 56. China Taiwan Pneumococcal Polysaccharide Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 57. Europe Pneumococcal Polysaccharide Vaccine Sales Market Share by Country in 2026
Figure 58. Europe Pneumococcal Polysaccharide Vaccine Revenue Market Share by Country (2021-2026)
Figure 59. Europe Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2021-2026)
Figure 60. Europe Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2021-2026)
Figure 61. Germany Pneumococcal Polysaccharide Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 62. France Pneumococcal Polysaccharide Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 63. UK Pneumococcal Polysaccharide Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 64. Italy Pneumococcal Polysaccharide Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 65. Russia Pneumococcal Polysaccharide Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 66. Middle East & Africa Pneumococcal Polysaccharide Vaccine Sales Market Share by Country (2021-2026)
Figure 67. Middle East & Africa Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2021-2026)
Figure 68. Middle East & Africa Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2021-2026)
Figure 69. Egypt Pneumococcal Polysaccharide Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 70. South Africa Pneumococcal Polysaccharide Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 71. Israel Pneumococcal Polysaccharide Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 72. Turkey Pneumococcal Polysaccharide Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 73. GCC Countries Pneumococcal Polysaccharide Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of Pneumococcal Polysaccharide Vaccine in 2026
Figure 75. Manufacturing Process Analysis of Pneumococcal Polysaccharide Vaccine
Figure 76. Industry Chain Structure of Pneumococcal Polysaccharide Vaccine
Figure 77. Channels of Distribution
Figure 78. Global Pneumococcal Polysaccharide Vaccine Sales Market Forecast by Region (2027-2032)
Figure 79. Global Pneumococcal Polysaccharide Vaccine Revenue Market Share Forecast by Region (2027-2032)
Figure 80. Global Pneumococcal Polysaccharide Vaccine Sales Market Share Forecast by Type (2027-2032)
Figure 81. Global Pneumococcal Polysaccharide Vaccine Revenue Market Share Forecast by Type (2027-2032)
Figure 82. Global Pneumococcal Polysaccharide Vaccine Sales Market Share Forecast by Application (2027-2032)
Figure 83. Global Pneumococcal Polysaccharide Vaccine Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Pneumococcal Polysaccharide Vaccine
Figure 2. Pneumococcal Polysaccharide Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Pneumococcal Polysaccharide Vaccine Sales Growth Rate 2021-2032 (Dose)
Figure 7. Global Pneumococcal Polysaccharide Vaccine Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Pneumococcal Polysaccharide Vaccine Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Pneumococcal Polysaccharide Vaccine Sales Market Share by Country/Region (2025)
Figure 10. Pneumococcal Polysaccharide Vaccine Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of PCV13
Figure 12. Product Picture of PPSV23
Figure 13. Product Picture of Others
Figure 14. Global Pneumococcal Polysaccharide Vaccine Sales Market Share by Type in 2026
Figure 15. Global Pneumococcal Polysaccharide Vaccine Revenue Market Share by Type (2021-2026)
Figure 16. Pneumococcal Polysaccharide Vaccine Consumed in Hospital
Figure 17. Global Pneumococcal Polysaccharide Vaccine Market: Hospital (2021-2026) & (Dose)
Figure 18. Pneumococcal Polysaccharide Vaccine Consumed in Centers for Disease Control and Prevention
Figure 19. Global Pneumococcal Polysaccharide Vaccine Market: Centers for Disease Control and Prevention (2021-2026) & (Dose)
Figure 20. Pneumococcal Polysaccharide Vaccine Consumed in Others
Figure 21. Global Pneumococcal Polysaccharide Vaccine Market: Others (2021-2026) & (Dose)
Figure 22. Global Pneumococcal Polysaccharide Vaccine Sale Market Share by Application (2025)
Figure 23. Global Pneumococcal Polysaccharide Vaccine Revenue Market Share by Application in 2026
Figure 24. Pneumococcal Polysaccharide Vaccine Sales by Company in 2026 (Dose)
Figure 25. Global Pneumococcal Polysaccharide Vaccine Sales Market Share by Company in 2026
Figure 26. Pneumococcal Polysaccharide Vaccine Revenue by Company in 2026 ($ millions)
Figure 27. Global Pneumococcal Polysaccharide Vaccine Revenue Market Share by Company in 2026
Figure 28. Global Pneumococcal Polysaccharide Vaccine Sales Market Share by Geographic Region (2021-2026)
Figure 29. Global Pneumococcal Polysaccharide Vaccine Revenue Market Share by Geographic Region in 2026
Figure 30. Americas Pneumococcal Polysaccharide Vaccine Sales 2021-2026 (Dose)
Figure 31. Americas Pneumococcal Polysaccharide Vaccine Revenue 2021-2026 ($ millions)
Figure 32. APAC Pneumococcal Polysaccharide Vaccine Sales 2021-2026 (Dose)
Figure 33. APAC Pneumococcal Polysaccharide Vaccine Revenue 2021-2026 ($ millions)
Figure 34. Europe Pneumococcal Polysaccharide Vaccine Sales 2021-2026 (Dose)
Figure 35. Europe Pneumococcal Polysaccharide Vaccine Revenue 2021-2026 ($ millions)
Figure 36. Middle East & Africa Pneumococcal Polysaccharide Vaccine Sales 2021-2026 (Dose)
Figure 37. Middle East & Africa Pneumococcal Polysaccharide Vaccine Revenue 2021-2026 ($ millions)
Figure 38. Americas Pneumococcal Polysaccharide Vaccine Sales Market Share by Country in 2026
Figure 39. Americas Pneumococcal Polysaccharide Vaccine Revenue Market Share by Country (2021-2026)
Figure 40. Americas Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2021-2026)
Figure 41. Americas Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2021-2026)
Figure 42. United States Pneumococcal Polysaccharide Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 43. Canada Pneumococcal Polysaccharide Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 44. Mexico Pneumococcal Polysaccharide Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 45. Brazil Pneumococcal Polysaccharide Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 46. APAC Pneumococcal Polysaccharide Vaccine Sales Market Share by Region in 2026
Figure 47. APAC Pneumococcal Polysaccharide Vaccine Revenue Market Share by Region (2021-2026)
Figure 48. APAC Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2021-2026)
Figure 49. APAC Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2021-2026)
Figure 50. China Pneumococcal Polysaccharide Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 51. Japan Pneumococcal Polysaccharide Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 52. South Korea Pneumococcal Polysaccharide Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 53. Southeast Asia Pneumococcal Polysaccharide Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 54. India Pneumococcal Polysaccharide Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 55. Australia Pneumococcal Polysaccharide Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 56. China Taiwan Pneumococcal Polysaccharide Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 57. Europe Pneumococcal Polysaccharide Vaccine Sales Market Share by Country in 2026
Figure 58. Europe Pneumococcal Polysaccharide Vaccine Revenue Market Share by Country (2021-2026)
Figure 59. Europe Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2021-2026)
Figure 60. Europe Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2021-2026)
Figure 61. Germany Pneumococcal Polysaccharide Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 62. France Pneumococcal Polysaccharide Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 63. UK Pneumococcal Polysaccharide Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 64. Italy Pneumococcal Polysaccharide Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 65. Russia Pneumococcal Polysaccharide Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 66. Middle East & Africa Pneumococcal Polysaccharide Vaccine Sales Market Share by Country (2021-2026)
Figure 67. Middle East & Africa Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2021-2026)
Figure 68. Middle East & Africa Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2021-2026)
Figure 69. Egypt Pneumococcal Polysaccharide Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 70. South Africa Pneumococcal Polysaccharide Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 71. Israel Pneumococcal Polysaccharide Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 72. Turkey Pneumococcal Polysaccharide Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 73. GCC Countries Pneumococcal Polysaccharide Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of Pneumococcal Polysaccharide Vaccine in 2026
Figure 75. Manufacturing Process Analysis of Pneumococcal Polysaccharide Vaccine
Figure 76. Industry Chain Structure of Pneumococcal Polysaccharide Vaccine
Figure 77. Channels of Distribution
Figure 78. Global Pneumococcal Polysaccharide Vaccine Sales Market Forecast by Region (2027-2032)
Figure 79. Global Pneumococcal Polysaccharide Vaccine Revenue Market Share Forecast by Region (2027-2032)
Figure 80. Global Pneumococcal Polysaccharide Vaccine Sales Market Share Forecast by Type (2027-2032)
Figure 81. Global Pneumococcal Polysaccharide Vaccine Revenue Market Share Forecast by Type (2027-2032)
Figure 82. Global Pneumococcal Polysaccharide Vaccine Sales Market Share Forecast by Application (2027-2032)
Figure 83. Global Pneumococcal Polysaccharide Vaccine Revenue Market Share Forecast by Application (2027-2032)
